Literature DB >> 15516721

Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice.

Kaku Nakagawa1, Hideyuki Kishida, Naoki Arai, Tozo Nishiyama, Tatsumasa Mae.   

Abstract

Licorice, the root of the Glycyrrhiza species, is one of the most frequently employed botanicals in traditional medicines. In this study, we investigated the effects of hydrophobic flavonoids from Glycyrrhiza glabra LINNE on abdominal fat accumulation and blood glucose level in obese diabetic KK-A(y) mice. In order to enrich a fraction of hydrophobic flavonoids, licorice flavonoid oil (LFO) was prepared by further extracting licorice ethanolic extract with medium-chain triglycerides (MCT), and adjusting the concentration of glabridin, the major flavonoid of licorice, to 1.2% in oil. KK-A(y) mice aged 6 weeks were assigned to 5 groups (n=6 each), and fed a high-fat diet containing 0 (control), 0.5%, 1%, or 2% LFO, or 0.5% conjugated linoleic acid (CLA) for 4 weeks. Compared with the control, body weight gain and weights of abdominal adipose tissues were suppressed (p<0.05) by feeding the diet containing 2% LFO, and blood glucose levels after 2 and 4 weeks were suppressed by all of the diets containing LFO. Although CLA feeding suppressed (p<0.05) body weight gain, it increased (p<0.05) blood glucose level after 2 weeks compared with the control level. Furthermore, LFO and licorice ethanolic extract stimulated human adipocyte differentiation in vitro. These results indicate that licorice hydrophobic flavonoids have abdominal fat-lowering and hypoglycemic effects, possibly mediated via activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516721     DOI: 10.1248/bpb.27.1775

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  19 in total

1.  Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients.

Authors:  Minpei Kuroda; Yoshihiro Mimaki; Takayuki Ohtomo; Junji Yamada; Tozo Nishiyama; Tatsumasa Mae; Hideyuki Kishida; Teruo Kawada
Journal:  J Nat Med       Date:  2011-10-11       Impact factor: 2.343

Review 2.  Phytochemistry and biological properties of glabridin.

Authors:  Charlotte Simmler; Guido F Pauli; Shao-Nong Chen
Journal:  Fitoterapia       Date:  2013-07-10       Impact factor: 2.882

3.  AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity.

Authors:  Joo-Won Lee; Sung Sik Choe; Hagoon Jang; Jiyeong Kim; Hyun Woo Jeong; Hyunsun Jo; Kyeong-Hoon Jeong; Surendar Tadi; Myoung Gyu Park; Tae Hwan Kwak; Jin Man Kim; Dong-Hoon Hyun; Jae Bum Kim
Journal:  J Lipid Res       Date:  2012-04-09       Impact factor: 5.922

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  Natural products and body weight control.

Authors:  Jay Lee; Yanmei Li; Chunhua Li; Duo Li
Journal:  N Am J Med Sci       Date:  2011-01

6.  A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity.

Authors:  Zach W Bell; Robert E Canale; Richard J Bloomer
Journal:  Lipids Health Dis       Date:  2011-02-10       Impact factor: 3.876

7.  Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus.

Authors:  R K Sharma; Pralhad S Patki
Journal:  J Ayurveda Integr Med       Date:  2010-01

8.  Effects of rhaponticum carthamoides versus glycyrrhiza glabra and punica granatum extracts on metabolic syndrome signs in rats.

Authors:  Michael Dushkin; Marina Khrapova; Gennadiy Kovshik; Marina Chasovskikh; Elena Menshchikova; Valeriy Trufakin; Anna Shurlygina; Evgeniy Vereschagin
Journal:  BMC Complement Altern Med       Date:  2014-01-20       Impact factor: 3.659

9.  Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats.

Authors:  Chia Yoke Yin; Ton So Ha; Khalid Abdul Kadir
Journal:  PPAR Res       Date:  2010       Impact factor: 4.964

10.  Hypolipidemic effects of three purgative decoctions.

Authors:  Sung-Hui Tseng; Ting-Yi Chien; Jiun-Rong Chen; I-Hsin Lin; Ching-Chiung Wang
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.